| Originator: |
|
National Patient Safety Alert - NHS England & NHS Improvement
|
 |
|
|
- Care Trusts
- Mental Health Trusts
- Specialists Trusts
- Learning Disabilities Trusts
- Mental Health & Social Care Trusts
- Ambulance Trusts
- Mental Health & Learning Disabilities Trusts
- Acute Trusts
- Community Trusts
|
|
|
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Regional Offices
- Special Health Authorities
- GP - Locum
- NHS 111 and Out of hours providers
- GP Practices
- Community Pharmacy
- Primary Care Networks
- GP Practices 1
|
| Title: |
|
Inadvertent oral administration of potassium permanganate
|
| Broadcast content: |
|
Potassium permanganate is supplied in concentrated forms, either as a ‘tablet’ or
a solution, which requires dilution before use. These concentrated forms
resemble an oral tablet or drink and if ingested are highly toxic.
The
alert asks both secondary and primary care providers to take action to assess
if use of potassium permanganate can be reduced; to ensure safer prescribing
and labelling, and to ensure it is stored safely.
|
| Additional information: |
|
NHS England and NHS Improvement Regional Offices: please cascade this alert to Community Pharmacy
|
| Action underway deadline: |
|
08-Apr-2022
|
| Action complete deadline: |
|
04-Oct-2022
|